Condition: Pulmonary Sarcoidosis · Sponsor: Molecure S.A.
This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01 in the treatment of subjects with active pulmonary sarcoidosis.
This description comes directly from the study's public registry record.
Theodoros Charitos, MD · +48789125928 · t.charitos@molecure.com
Always discuss trial participation with your own doctor first.
| Molecure Investigative Site | Birmingham, Alabama, United States | Withdrawn |
| Molecure Investigative Site | Kansas City, Kansas, United States | Withdrawn |
| Molecure Investigative Site | Baltimore, Maryland, United States | Recruiting |
| Molecure Investigative Site | Rochester, Minnesota, United States | Withdrawn |
| Molecure Investigative Site | Cleveland, Ohio, United States | Recruiting |
| Molecure Investigative Site | Philadelphia, Pennsylvania, United States | Recruiting |
| Molecure Investigative Site | Charleston, South Carolina, United States | Recruiting |
| Molecure Investigative Site | Vejle, Denmark | Withdrawn |
| Molecure Investigative Site | Bobigny, France | Withdrawn |
| Molecure Investigative Site | Montpellier, France | Recruiting |
| Molecure Investigative Site | Paris, France | Recruiting |
| Molecure Investigative Site | Paris, France | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06205121